- Home
- PHH vs PULM Comparison
PHH vs PULM Comparison
Compare PHH & PULM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHH
- PULM
- Stock Information
- Founded
- PHH 2016
- PULM 2003
- Country
- PHH China
- PULM United States
- Employees
- PHH N/A
- PULM N/A
- Industry
- PHH Package Goods/Cosmetics
- PULM Biotechnology: Pharmaceutical Preparations
- Sector
- PHH Consumer Discretionary
- PULM Health Care
- Exchange
- PHH Nasdaq
- PULM Nasdaq
- Market Cap
- PHH 16.2M
- PULM 18.3M
- IPO Year
- PHH 2024
- PULM N/A
- Fundamental
- Price
- PHH $0.38
- PULM $4.92
- Analyst Decision
- PHH
- PULM
- Analyst Count
- PHH 0
- PULM 0
- Target Price
- PHH N/A
- PULM N/A
- AVG Volume (30 Days)
- PHH 386.5K
- PULM 19.7K
- Earning Date
- PHH 08-26-2025
- PULM 10-16-2025
- Dividend Yield
- PHH N/A
- PULM N/A
- EPS Growth
- PHH N/A
- PULM N/A
- EPS
- PHH N/A
- PULM N/A
- Revenue
- PHH $2,768,120.00
- PULM $3,000.00
- Revenue This Year
- PHH N/A
- PULM N/A
- Revenue Next Year
- PHH N/A
- PULM $134.88
- P/E Ratio
- PHH N/A
- PULM N/A
- Revenue Growth
- PHH 42.65
- PULM N/A
- 52 Week Low
- PHH $0.38
- PULM $1.96
- 52 Week High
- PHH $41.49
- PULM $10.40
- Technical
- Relative Strength Index (RSI)
- PHH 25.95
- PULM 52.06
- Support Level
- PHH $0.38
- PULM $4.58
- Resistance Level
- PHH $0.43
- PULM $5.00
- Average True Range (ATR)
- PHH 0.03
- PULM 0.27
- MACD
- PHH 0.06
- PULM 0.01
- Stochastic Oscillator
- PHH 9.08
- PULM 45.27
About PHH Park Ha Biological Technology Co. Ltd. Ordinary Shares
Park Ha Biological Technology Co Ltd is engaged in developing its private skincare label, direct skincare products sales and franchise alliances promotions. Its Park Ha brand focuses on providing solutions for problematic skin. The company's Operating Subsidiaries provide skincare and cosmetic products under its brand, Park Ha in China. Its Operating Subsidiaries develop its proprietary beauty products and offer complimentary after-sales beauty services in its physical stores.
About PULM Pulmatrix Inc.
Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).